122 related articles for article (PubMed ID: 9291424)
1. Relation between aberrant alpha-catenin expression and loss of E-cadherin function in prostate cancer.
Umbas R; Isaacs WB; Bringuier PP; Xue Y; Debruyne FM; Schalken JA
Int J Cancer; 1997 Aug; 74(4):374-7. PubMed ID: 9291424
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of E-cadherin and the cadherin-associated molecules alpha-, beta-, gamma-catenin and p120ctn in prostate cancer specific survival: a long-term follow-up study.
van Oort IM; Tomita K; van Bokhoven A; Bussemakers MJ; Kiemeney LA; Karthaus HF; Witjes JA; Schalken JA
Prostate; 2007 Sep; 67(13):1432-8. PubMed ID: 17639504
[TBL] [Abstract][Full Text] [Related]
3. Reduction of E-cadherin levels and deletion of the alpha-catenin gene in human prostate cancer cells.
Morton RA; Ewing CM; Nagafuchi A; Tsukita S; Isaacs WB
Cancer Res; 1993 Aug; 53(15):3585-90. PubMed ID: 8339265
[TBL] [Abstract][Full Text] [Related]
4. Alpha-catenin expression has prognostic value in local and locally advanced prostate cancer.
Aaltomaa S; Lipponen P; Ala-Opas M; Eskelinen M; Kosma VM
Br J Cancer; 1999 May; 80(3-4):477-82. PubMed ID: 10408856
[TBL] [Abstract][Full Text] [Related]
5. Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival.
Richmond PJ; Karayiannakis AJ; Nagafuchi A; Kaisary AV; Pignatelli M
Cancer Res; 1997 Aug; 57(15):3189-93. PubMed ID: 9242448
[TBL] [Abstract][Full Text] [Related]
6. Cadherin switching in human prostate cancer progression.
Tomita K; van Bokhoven A; van Leenders GJ; Ruijter ET; Jansen CF; Bussemakers MJ; Schalken JA
Cancer Res; 2000 Jul; 60(13):3650-4. PubMed ID: 10910081
[TBL] [Abstract][Full Text] [Related]
7. Expression of E-cadherin and alpha-, beta-, gamma-catenin proteins in endometrial carcinoma.
Kim YT; Choi EK; Kim JW; Kim DK; Kim SH; Yang WI
Yonsei Med J; 2002 Dec; 43(6):701-11. PubMed ID: 12497652
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of E-cadherin and beta-catenin in resected stage I non-small cell lung cancer.
Choi YS; Shim YM; Kim SH; Son DS; Lee HS; Kim GY; Han J; Kim J
Eur J Cardiothorac Surg; 2003 Sep; 24(3):441-9. PubMed ID: 12965318
[TBL] [Abstract][Full Text] [Related]
9. Complex cadherin expression in human prostate cancer cells.
Bussemakers MJ; Van Bokhoven A; Tomita K; Jansen CF; Schalken JA
Int J Cancer; 2000 Feb; 85(3):446-50. PubMed ID: 10652439
[TBL] [Abstract][Full Text] [Related]
10. Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Umbas R; Isaacs WB; Bringuier PP; Schaafsma HE; Karthaus HF; Oosterhof GO; Debruyne FM; Schalken JA
Cancer Res; 1994 Jul; 54(14):3929-33. PubMed ID: 7518346
[TBL] [Abstract][Full Text] [Related]
11. Immune expression of E-cadherin and α, β and γ-Catenin adhesion molecules and prognosis for upper urinary tract urothelial carcinomas.
Reis ST; Leite KR; Mosconi Neto A; Pontes Júnior J; Viana NI; Antunes AA; Dall'Oglio MF; Srougi M
Int Braz J Urol; 2012; 38(4):466-73. PubMed ID: 22951176
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns of alpha-, beta- and gamma-catenin in pancreatic cancer: correlation with E-cadherin expression, pathological features and prognosis.
Karayiannakis AJ; Syrigos KN; Polychronidis A; Simopoulos C
Anticancer Res; 2001; 21(6A):4127-34. PubMed ID: 11911306
[TBL] [Abstract][Full Text] [Related]
13. E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis.
Tsiambas E; Ragos V; Georgakopoulos G; Rigopoulos DN; Fotiades PP; Chatziioannidis A; Stamatelopoulos A; Vilaras G; Karameris A
J BUON; 2016; 21(2):450-5. PubMed ID: 27273957
[TBL] [Abstract][Full Text] [Related]
14. Coordinate recruitment of E-cadherin and ALCAM to cell-cell contacts by alpha-catenin.
Tomita K; van Bokhoven A; Jansen CF; Bussemakers MJ; Schalken JA
Biochem Biophys Res Commun; 2000 Jan; 267(3):870-4. PubMed ID: 10673383
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 5 suppresses tumorigenicity of PC3 prostate cancer cells: correlation with re-expression of alpha-catenin and restoration of E-cadherin function.
Ewing CM; Ru N; Morton RA; Robinson JC; Wheelock MJ; Johnson KR; Barrett JC; Isaacs WB
Cancer Res; 1995 Nov; 55(21):4813-7. PubMed ID: 7585512
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin and alpha-, beta- and gamma-catenin expression in prostate cancers: correlation with tumour invasion.
Morita N; Uemura H; Tsumatani K; Cho M; Hirao Y; Okajima E; Konishi N; Hiasa Y
Br J Cancer; 1999 Apr; 79(11-12):1879-83. PubMed ID: 10206308
[TBL] [Abstract][Full Text] [Related]
17. Changes in the E-cadherin-catenin complex expression in early and advanced gastric cancers.
Joo YE; Rew JS; Kim HS; Choi SH; Park CS; Kim SJ
Digestion; 2001; 64(2):111-9. PubMed ID: 11684825
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of the expression of E-cadherin and beta-catenin in bladder cancer.
Garcia del Muro X; Torregrosa A; Muñoz J; Castellsagué X; Condom E; Vigués F; Arance A; Fabra A; Germà JR
Eur J Cancer; 2000 Feb; 36(3):357-62. PubMed ID: 10708937
[TBL] [Abstract][Full Text] [Related]
19. P-cadherin expression in breast carcinoma indicates poor survival.
Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA
Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713
[TBL] [Abstract][Full Text] [Related]
20. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer.
Lim SC; Lee MS
Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]